Page last updated: 2024-10-31

mianserin and Liver Steatosis

mianserin has been researched along with Liver Steatosis in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research Excerpts

ExcerptRelevanceReference
"Mirtazapine is a commonly used drug indicated for the treatment of severe depression."1.46Mirtazapine-induced steatosis
. ( Ch'ng, CL; Haboubi, H; Lloyd, A; Thomas, E; Williams, N, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thomas, E1
Haboubi, H1
Williams, N1
Lloyd, A1
Ch'ng, CL1

Other Studies

1 other study available for mianserin and Liver Steatosis

ArticleYear
Mirtazapine-induced steatosis
.
    International journal of clinical pharmacology and therapeutics, 2017, Volume: 55, Issue:7

    Topics: Adrenergic alpha-2 Receptor Antagonists; Antidepressive Agents, Tricyclic; Biopsy; Chemical and Drug

2017